The health in our hands! Unlocking public health outcomes by combining science & digital technology

In case you missed it, catch up with Michelle Rohrer, Global Head of Regulatory, and an expert panel to reflect on the opportunities and what it will take to unlock the promise of biomedical science combined with ubiquitous technology, for patients, health systems, and society.

Panelists:
Michelle Rohrer, Global Head of Regulatory, Roche (Moderator)
Prof. Dr. Effy Vayena, Professor at ETH Zuerich (Health Ethics and Policy Lab, Institute of Translational Medicine)
Jan Geissler, Patient advocate and CEO at Patvocates
KT Park, Global Head of Gastroenterology & Hepatology, Clinical Development, Roche Genentech
Tomas Salmonson, Consilium Salmonson & Hemmings


Get in touch with us:

Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.

Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.